In the latest funding developments in China, Shanghai-based pharma company Harbour BioMed said it has completed Series A+ round of financing led by Chinese private equity firm CDH Investments, while Hive Box has raised $323 million in a strategic financing round from a group of investors.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
